Competitive Inhibition of Human Brain Hexokinase by Metrizamide and Related Compounds

John M. Bertoni, Susan T. Weintraub

Research output: Contribution to journalArticle

7 Citations (Scopus)

Abstract

Abstract: We have compared the competitive inhibitory effects of 2‐deoxyglucose, glucosamine, N‐acetylglucosamine, N‐benzoylglucosamine, and the commonly used radiographic and density gradient agent metrizamide (2‐[3 ‐ acetamido ‐ 2,4,6 ‐ triiodo ‐5‐(N‐ methylacetamido) benzamido]‐2‐deoxyglucose) on the mitochondrial and soluble forms of human brain hexokinase. Metrizamide produces a classical competitive inhibition with glucose for human brain hexokinase, with Kis of 2.8 and 2.5 mM, respectively, for the mitochondrial and soluble forms. Glucosamine exhibited Kis of 0.58 and 0.29 mM, while 2‐deoxyglucose exhibited Kis of 0.074 and 0.15 mM and N‐acetylglucosamine 0.098 and 0.092 mM for these two forms, respectively. N‐Benzoylglucosamine was by far the most effective inhibitor tested, with Ki values of 0.0086 and 0.022 mM, respectively. In order of increasing potency as a competitive inhibitor for mitochondrial hexokinase are metrizamide, glucosamine, N‐acetylglucosamine, 2‐deoxyglucose, and N‐benzoylglucosamine. For the soluble form of the enzyme in increasing potency are metrizamide, glucosamine, 2‐deoxyglucose, N‐acetylglucosamine, and N‐benzoylglucosamine. Since N‐benzoylglucosamine was over 100 times more potent than metrizamide, some of the effects of metrizamide could be due to contamination by N‐benzoylglucosamine. However, gas chromatography‐mass spectrometry analysis of metrizamide did not indicate the presence of N‐benzoylglucosamine. In addition, column chromatographic separation of commercially available metrizamide and reconstitution of freeze‐dried eluate fractions localized the inhibitory effect to the metrizamide peak.

Original languageEnglish (US)
Pages (from-to)513-518
Number of pages6
JournalJournal of Neurochemistry
Volume42
Issue number2
DOIs
StatePublished - Feb 1984

Fingerprint

Metrizamide
Hexokinase
Brain
Glucosamine
Spectrometry
Spectrum Analysis
Contamination
Gases
Glucose

Keywords

  • Brain
  • Deoxyglucose
  • Glucosamine
  • Hexokinase
  • Human
  • Inhibitor
  • Metrizamide

ASJC Scopus subject areas

  • Biochemistry
  • Cellular and Molecular Neuroscience

Cite this

Competitive Inhibition of Human Brain Hexokinase by Metrizamide and Related Compounds. / Bertoni, John M.; Weintraub, Susan T.

In: Journal of Neurochemistry, Vol. 42, No. 2, 02.1984, p. 513-518.

Research output: Contribution to journalArticle

@article{3bfc970a04b743ec89c9f8db74a589d0,
title = "Competitive Inhibition of Human Brain Hexokinase by Metrizamide and Related Compounds",
abstract = "Abstract: We have compared the competitive inhibitory effects of 2‐deoxyglucose, glucosamine, N‐acetylglucosamine, N‐benzoylglucosamine, and the commonly used radiographic and density gradient agent metrizamide (2‐[3 ‐ acetamido ‐ 2,4,6 ‐ triiodo ‐5‐(N‐ methylacetamido) benzamido]‐2‐deoxyglucose) on the mitochondrial and soluble forms of human brain hexokinase. Metrizamide produces a classical competitive inhibition with glucose for human brain hexokinase, with Kis of 2.8 and 2.5 mM, respectively, for the mitochondrial and soluble forms. Glucosamine exhibited Kis of 0.58 and 0.29 mM, while 2‐deoxyglucose exhibited Kis of 0.074 and 0.15 mM and N‐acetylglucosamine 0.098 and 0.092 mM for these two forms, respectively. N‐Benzoylglucosamine was by far the most effective inhibitor tested, with Ki values of 0.0086 and 0.022 mM, respectively. In order of increasing potency as a competitive inhibitor for mitochondrial hexokinase are metrizamide, glucosamine, N‐acetylglucosamine, 2‐deoxyglucose, and N‐benzoylglucosamine. For the soluble form of the enzyme in increasing potency are metrizamide, glucosamine, 2‐deoxyglucose, N‐acetylglucosamine, and N‐benzoylglucosamine. Since N‐benzoylglucosamine was over 100 times more potent than metrizamide, some of the effects of metrizamide could be due to contamination by N‐benzoylglucosamine. However, gas chromatography‐mass spectrometry analysis of metrizamide did not indicate the presence of N‐benzoylglucosamine. In addition, column chromatographic separation of commercially available metrizamide and reconstitution of freeze‐dried eluate fractions localized the inhibitory effect to the metrizamide peak.",
keywords = "Brain, Deoxyglucose, Glucosamine, Hexokinase, Human, Inhibitor, Metrizamide",
author = "Bertoni, {John M.} and Weintraub, {Susan T.}",
year = "1984",
month = "2",
doi = "10.1111/j.1471-4159.1984.tb02707.x",
language = "English (US)",
volume = "42",
pages = "513--518",
journal = "Journal of Neurochemistry",
issn = "0022-3042",
publisher = "Wiley-Blackwell",
number = "2",

}

TY - JOUR

T1 - Competitive Inhibition of Human Brain Hexokinase by Metrizamide and Related Compounds

AU - Bertoni, John M.

AU - Weintraub, Susan T.

PY - 1984/2

Y1 - 1984/2

N2 - Abstract: We have compared the competitive inhibitory effects of 2‐deoxyglucose, glucosamine, N‐acetylglucosamine, N‐benzoylglucosamine, and the commonly used radiographic and density gradient agent metrizamide (2‐[3 ‐ acetamido ‐ 2,4,6 ‐ triiodo ‐5‐(N‐ methylacetamido) benzamido]‐2‐deoxyglucose) on the mitochondrial and soluble forms of human brain hexokinase. Metrizamide produces a classical competitive inhibition with glucose for human brain hexokinase, with Kis of 2.8 and 2.5 mM, respectively, for the mitochondrial and soluble forms. Glucosamine exhibited Kis of 0.58 and 0.29 mM, while 2‐deoxyglucose exhibited Kis of 0.074 and 0.15 mM and N‐acetylglucosamine 0.098 and 0.092 mM for these two forms, respectively. N‐Benzoylglucosamine was by far the most effective inhibitor tested, with Ki values of 0.0086 and 0.022 mM, respectively. In order of increasing potency as a competitive inhibitor for mitochondrial hexokinase are metrizamide, glucosamine, N‐acetylglucosamine, 2‐deoxyglucose, and N‐benzoylglucosamine. For the soluble form of the enzyme in increasing potency are metrizamide, glucosamine, 2‐deoxyglucose, N‐acetylglucosamine, and N‐benzoylglucosamine. Since N‐benzoylglucosamine was over 100 times more potent than metrizamide, some of the effects of metrizamide could be due to contamination by N‐benzoylglucosamine. However, gas chromatography‐mass spectrometry analysis of metrizamide did not indicate the presence of N‐benzoylglucosamine. In addition, column chromatographic separation of commercially available metrizamide and reconstitution of freeze‐dried eluate fractions localized the inhibitory effect to the metrizamide peak.

AB - Abstract: We have compared the competitive inhibitory effects of 2‐deoxyglucose, glucosamine, N‐acetylglucosamine, N‐benzoylglucosamine, and the commonly used radiographic and density gradient agent metrizamide (2‐[3 ‐ acetamido ‐ 2,4,6 ‐ triiodo ‐5‐(N‐ methylacetamido) benzamido]‐2‐deoxyglucose) on the mitochondrial and soluble forms of human brain hexokinase. Metrizamide produces a classical competitive inhibition with glucose for human brain hexokinase, with Kis of 2.8 and 2.5 mM, respectively, for the mitochondrial and soluble forms. Glucosamine exhibited Kis of 0.58 and 0.29 mM, while 2‐deoxyglucose exhibited Kis of 0.074 and 0.15 mM and N‐acetylglucosamine 0.098 and 0.092 mM for these two forms, respectively. N‐Benzoylglucosamine was by far the most effective inhibitor tested, with Ki values of 0.0086 and 0.022 mM, respectively. In order of increasing potency as a competitive inhibitor for mitochondrial hexokinase are metrizamide, glucosamine, N‐acetylglucosamine, 2‐deoxyglucose, and N‐benzoylglucosamine. For the soluble form of the enzyme in increasing potency are metrizamide, glucosamine, 2‐deoxyglucose, N‐acetylglucosamine, and N‐benzoylglucosamine. Since N‐benzoylglucosamine was over 100 times more potent than metrizamide, some of the effects of metrizamide could be due to contamination by N‐benzoylglucosamine. However, gas chromatography‐mass spectrometry analysis of metrizamide did not indicate the presence of N‐benzoylglucosamine. In addition, column chromatographic separation of commercially available metrizamide and reconstitution of freeze‐dried eluate fractions localized the inhibitory effect to the metrizamide peak.

KW - Brain

KW - Deoxyglucose

KW - Glucosamine

KW - Hexokinase

KW - Human

KW - Inhibitor

KW - Metrizamide

UR - http://www.scopus.com/inward/record.url?scp=0021332690&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0021332690&partnerID=8YFLogxK

U2 - 10.1111/j.1471-4159.1984.tb02707.x

DO - 10.1111/j.1471-4159.1984.tb02707.x

M3 - Article

C2 - 6693884

AN - SCOPUS:0021332690

VL - 42

SP - 513

EP - 518

JO - Journal of Neurochemistry

JF - Journal of Neurochemistry

SN - 0022-3042

IS - 2

ER -